Trial Profile
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 May 2012 Planned End Date changed from 1 Feb 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 09 Dec 2009 Planned end date changed from 1 Sep 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.